Yaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing
Read more here
News
Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here
Yaupon Therapeutics, Inc. Appoints New Management Team
Read more here
First-In-Class Novel Anti-Cancer Agent In Development By Niiki Pharma Shows Promising Phase I Results
Read more here
Infrascannerâ„¢ Software Designer Wins the Design of Medical Devices Top Award
Read more here
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Read more here
Jeffrey Cummings, Rachelle Doody, Martin Farlow and Mary Sano to Form QR Pharma’s Medical Advisory Board
Read more here
TREVENTIS Corporation Founder Wins Prestigious Discovery Award
Read more here